Francesca Reindel is an Associate at New Science Ventures, a New York-based venture capital firm which invests in companies using novel scientific approaches in the Life Sciences and Information Technology sectors. Prior to joining NSV, she was a Senior Consultant at Easton Associates (acquired by Navigant), a healthcare consulting firm that specializes in new product evaluation and strategic planning for companies across the pharmaceutical, biotechnology, and medical device industries. She graduated from Harvard University in 2011 with an A.B. degree with High Honors in Neurobiology and with a Certificate in Mind/Brain/Behavior.